Skip to content
Friday, March 24, 2023
HealthCare Middle East & Africa Logo 500

No.1 Healthcare & Pharma Industry Magazine for Middle East & Africa

  • HOME
  • TOPICS
    • MERGERS, INVESTMENTS & FUNDING
    • DISEASES UPDATES
    • HOSPITALS
    • PHARMACEUTICALS
    • PEOPLE NEWS
  • THE MAGAZINE
    • About HealthCare Middle East & Africa Magazine
    • PRESS RELEASES
    • SUBSCRIBE TO EMAIL NEWSLETTERS
  • ADVERTISE
  • PROFILES & INTERVIEWS
  • OUR EVENTS
  • CONTACT US
BREAKING NEWS
  • UAE-based AstraGene and Mylab form joint venture to commercialize automated diagnostics
  • Chinese missionaries in Rwanda perform painless normal delivery
  • <strong>OSHCO, VAMED Group to establish a new rehabilitation & long-term care hospital in Riyadh</strong>
  • Uganda launches project to scale up paediatric surgical services in hospitals
  • <strong>Dubai’s state-owned DAHC, Pfizer, AXDEV Group ally to enhance chronic illness care</strong>
  • Macra supports Ministry of Health with US$53,296 cholera materials
  • KFSH&RC to debut its Digital Health Conference in Riyadh
  • NPHCDA launches project to prevent maternal health challenges
  • <strong>Saudi’s KAEC inks health cooperation pact with Dr. Sulaiman Al Habib Medical Group</strong>
  • Africa has the highest global surge in oral diseases - WHO
You are here
  • Home
  • Covid-19

Tag: Covid-19

Covid-19 pill delivered to high-risk patients in four African countries through Quick Start Consortium

17 March 202317 March 2023

AFRICA – The COVID Treatment Quick Start Consortium has announced that the governments of Zambia, Laos, Malawi and Rwanda have received shipments of PAXLOVID (nirmatrelvir/ritonavir), Pfizer’s COVID-19 oral treatment. Partners…

Read More

FDA advisory panel supports full approval of Pfizer’s COVID therapy

17 March 202317 March 2023

USA —Advisers to the U.S. Food and Drug Administration gave strong support for full approval of Pfizer’s oral antiviral COVID-19 treatment, Paxlovid, for adults at high risk of severe disease…

Read More

Merck appeals EMA’s decision to reject Covid-19 antiviral drug

14 March 202314 March 2023

NETHERLANDS — Merck is appealing the EMA’s rejection of its Covid-19 pill, Lagevrio, which serves as an alternative to Pfizer’s Paxlovid. The EMA stated that they couldn’t conclude that Lagevrio…

Read More

COVID-19 vaccination coverage rises in Africa from EU and WHO project

9 March 20239 March 2023

AFRICA – European Union-funded, WHO-led two-year project has risen the number of COVID-19 vaccination in many vulnerable African communities. At the start of 2022, the COVID-19 vaccination rate was less…

Read More

Biopharma industry rebounds from the COVID-19 pandemic, resumes pre-pandemic levels of investment: IQVIA Report

7 March 20237 March 2023

USA—IQVIA’s latest report on the biopharmaceutical industry shows that it has rebounded from the COVID-19 pandemic and is returning to pre-pandemic levels of investment, pipeline activity, and launch of novel…

Read More

Merck’s COVID pill faces rejection from European regulator

28 February 202328 February 2023

NETHERLANDS — Merck and Ridgeback Biotherapeutics’ COVID-19 pill Lagevrio has been recommended against approval by a key committee of the European Medicines Agency (EMA). The committee concluded that a clinical…

Read More

University of Sydney researchers discover new protein that hinders Covid-19

10 February 202313 February 2023

AUSTRALIA — University of Sydney scientists have discovered a protein in the lung that blocks SARS-CoV-2 infection and forms a natural protective barrier in the human body. The leucine-rich repeat-containing…

Read More

Nigeria surpasses its milestone of vaccinating 30% of its population against Covid-19

30 January 202330 January 2023

NIGERIA – Nigeria, with the support of Gavi, the Vaccine Alliance, has surpassed the milestone of fully vaccinating 30 per cent of its total population. Nigeria has maintained a sustained…

Read More

FDA revokes authorization for AstraZeneca’s Covid antibody drug Evusheld citing ineffectiveness

29 January 202330 January 2023

USA — Evusheld, a preventative monoclonal antibody treatment for COVID-19, has lost its emergency use authorization in the United States because it is unlikely to be effective against the coronavirus…

Read More

CoVDP donates US$2.8m equipment to boost Sierra Leone vaccination efforts

26 January 202326 January 2023

SIERRA LEONE – Government of Sierra Leone has received vehicles including motorbikes and computers worth over US$2.8 million from the COVID-19 Vaccine Delivery Partnership, (CoVDP), for vaccine deployment. CoVDP is…

Read More

Posts navigation

Older posts

LATEST DIGITAL MAGAZINE

LATEST NEWS

  • UAE-based AstraGene and Mylab form joint venture to commercialize automated diagnostics
  • Chinese missionaries in Rwanda perform painless normal delivery
  • OSHCO, VAMED Group to establish a new rehabilitation & long-term care hospital in Riyadh
  • Uganda launches project to scale up paediatric surgical services in hospitals
  • Dubai’s state-owned DAHC, Pfizer, AXDEV Group ally to enhance chronic illness care

MOST POPULAR TAGS

Africa Africa CDC Artificial Intelligence AstraZeneca Cancer Covid-19 Diabetes Digital health Egypt France Germany Ghana GSK Healthcare Delivery HIV/AIDS Hospitals India Japan Johnson & Johnson Kenya Malaria Merck Mergers, Investments & Funding Middle East and North Africa Moderna MOH Kenya Nigeria Novartis Partnerships Pfizer Pharmaceuticals Public Health Roche Science & Technology South Africa Switzerland Tanzania UAE Uganda UK UNICEF USA US FDA Vaccines WHO

ARCHIVES

ABOUT FW AFRICA

We organise some of the most impactful face to face and virtual trade events and publish leading magazines and websites that bring Africa to the World and the World to Africa. We believe that when people come together, networks grow and businesses thrive.

Find more about us on our corporate website www.fwafrica.net

RELATED PUBLICATIONS

CEO Business Africa

Food Business Africa

Food Safety Africa

Milling & Baking Africa

Sustainable Packaging Africa

CONTACT US

FW Africa

P.O. Box 1874-00621, Nairobi, Kenya

Tel: +254 725 34 39 32

Email: info@fwafrica.net

Copyright © All rights reserved. FW Africa. We are not responsible for content from external sites.